Nifty
Sensex
:
:
24971.90
81896.79
-140.50 (-0.56%)
-511.38 (-0.62%)

Pharmaceuticals & Drugs - API

Rating :
57/99

BSE: 532482 | NSE: GRANULES

497.25
23-Jun-2025
  • Open
  • High
  • Low
  • Previous Close
  •  482.8
  •  499.7
  •  482.05
  •  487.35
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1177008
  •  580875703.3
  •  721
  •  422

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 12,070.31
  • 24.07
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 12,759.72
  • 0.30%
  • 3.25

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 38.84%
  • 3.35%
  • 16.07%
  • FII
  • DII
  • Others
  • 15.14%
  • 21.70%
  • 4.90%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.30
  • 11.64
  • 6.18

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.16
  • 10.26
  • 3.47

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.12
  • 5.51
  • -0.61

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.07
  • 18.28
  • 23.42

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.98
  • 3.49
  • 3.28

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 11.19
  • 11.89
  • 12.26

Earnings Forecasts:

(Updated: 06-06-2025)
Description
2024
2025
2026
2027
Adj EPS
16.73
20.69
24.42
30.92
P/E Ratio
29.72
24.03
20.36
16.08
Revenue
4506
4482
5179
5981
EBITDA
856
945
1126
1359
Net Income
405
502
594
752
ROA
7.8
8.5
P/B Ratio
3.87
3.25
2.83
2.45
ROE
13.38
14.45
14.47
15.72
FCFF
-41
195
352
574
FCFF Yield
-0.31
1.46
2.63
4.29
Net Debt
929
699
957
785
BVPS
128.36
153.22
175.66
203.19

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Net Sales
1,197.43
1,175.78
1.84%
1,137.70
1,155.58
-1.55%
966.62
1,189.49
-18.74%
1,179.87
985.52
19.72%
Expenses
945.07
920.08
2.72%
907.40
905.10
0.25%
763.30
976.51
-21.83%
920.60
848.69
8.47%
EBITDA
252.36
255.70
-1.31%
230.29
250.48
-8.06%
203.32
212.97
-4.53%
259.27
136.82
89.50%
EBIDTM
21.07%
21.75%
20.24%
21.68%
21.03%
17.90%
21.97%
13.88%
Other Income
1.92
1.87
2.67%
5.68
0.65
773.85%
3.25
1.53
112.42%
2.06
0.35
488.57%
Interest
23.98
28.76
-16.62%
26.57
28.65
-7.26%
25.67
25.96
-1.12%
27.02
22.46
20.30%
Depreciation
63.50
53.18
19.41%
56.61
52.39
8.05%
52.52
52.52
0.00%
52.87
49.24
7.37%
PBT
197.55
175.64
12.47%
152.79
170.09
-10.17%
128.38
136.02
-5.62%
181.44
65.47
177.13%
Tax
45.52
45.99
-1.02%
35.19
44.44
-20.81%
31.15
33.91
-8.14%
46.79
17.58
166.15%
PAT
152.03
129.65
17.26%
117.60
125.65
-6.41%
97.23
102.12
-4.79%
134.65
47.89
181.17%
PATM
12.70%
11.03%
10.34%
10.87%
10.06%
8.58%
11.41%
4.86%
EPS
6.27
5.35
17.20%
4.85
5.18
-6.37%
4.01
4.21
-4.75%
5.56
1.98
180.81%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
4,481.62
4,506.37
4,511.92
3,764.92
3,237.54
2,598.65
2,279.20
1,684.62
1,410.57
1,357.18
1,292.92
Net Sales Growth
-0.55%
-0.12%
19.84%
16.29%
24.59%
14.02%
35.29%
19.43%
3.93%
4.97%
 
Cost Of Goods Sold
1,725.71
2,021.25
2,307.28
1,883.64
1,391.28
1,280.93
1,255.56
896.32
679.63
725.03
746.95
Gross Profit
2,755.91
2,485.12
2,204.63
1,881.28
1,846.27
1,317.72
1,023.64
788.30
730.93
632.15
545.97
GP Margin
61.49%
55.15%
48.86%
49.97%
57.03%
50.71%
44.91%
46.79%
51.82%
46.58%
42.23%
Total Expenditure
3,536.37
3,650.39
3,598.60
3,043.30
2,382.31
2,073.33
1,895.16
1,406.20
1,111.73
1,081.29
1,084.31
Power & Fuel Cost
-
100.64
95.69
74.66
68.85
59.74
57.67
48.22
38.67
34.97
45.73
% Of Sales
-
2.23%
2.12%
1.98%
2.13%
2.30%
2.53%
2.86%
2.74%
2.58%
3.54%
Employee Cost
-
550.24
420.35
366.44
324.29
259.04
209.82
165.21
140.19
117.57
106.96
% Of Sales
-
12.21%
9.32%
9.73%
10.02%
9.97%
9.21%
9.81%
9.94%
8.66%
8.27%
Manufacturing Exp.
-
408.01
273.93
298.74
228.39
177.94
157.62
120.84
88.60
66.97
50.89
% Of Sales
-
9.05%
6.07%
7.93%
7.05%
6.85%
6.92%
7.17%
6.28%
4.93%
3.94%
General & Admin Exp.
-
211.99
187.96
134.41
172.28
125.63
99.96
83.05
67.65
60.38
59.84
% Of Sales
-
4.70%
4.17%
3.57%
5.32%
4.83%
4.39%
4.93%
4.80%
4.45%
4.63%
Selling & Distn. Exp.
-
290.63
280.00
247.45
159.80
112.17
91.84
83.08
81.37
67.75
71.70
% Of Sales
-
6.45%
6.21%
6.57%
4.94%
4.32%
4.03%
4.93%
5.77%
4.99%
5.55%
Miscellaneous Exp.
-
67.62
33.38
37.96
37.42
57.88
22.69
9.49
15.61
8.62
71.70
% Of Sales
-
1.50%
0.74%
1.01%
1.16%
2.23%
1.00%
0.56%
1.11%
0.64%
0.17%
EBITDA
945.24
855.98
913.32
721.62
855.23
525.32
384.04
278.42
298.84
275.89
208.61
EBITDA Margin
21.09%
18.99%
20.24%
19.17%
26.42%
20.22%
16.85%
16.53%
21.19%
20.33%
16.13%
Other Income
12.91
4.40
14.29
18.22
26.88
36.56
26.68
10.84
9.93
5.62
4.34
Interest
103.24
105.82
55.93
23.21
26.28
27.02
28.46
33.06
32.26
37.07
32.35
Depreciation
225.50
207.33
184.49
158.63
151.46
136.95
105.48
76.20
71.51
58.40
52.65
PBT
660.16
547.23
687.17
558.00
704.36
397.90
276.78
180.00
204.99
186.03
127.96
Tax
158.65
141.92
170.58
145.24
154.91
115.73
89.11
63.40
65.20
61.15
37.05
Tax Rate
24.03%
25.93%
24.82%
26.03%
21.99%
27.19%
32.20%
35.22%
31.81%
32.87%
28.95%
PAT
501.51
405.31
516.60
412.76
549.46
309.91
187.67
116.60
139.79
124.89
90.91
PAT before Minority Interest
501.51
405.31
516.60
412.76
549.46
309.91
187.67
116.60
139.79
124.89
90.91
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
11.19%
8.99%
11.45%
10.96%
16.97%
11.93%
8.23%
6.92%
9.91%
9.20%
7.03%
PAT Growth
23.73%
-21.54%
25.16%
-24.88%
77.30%
65.14%
60.95%
-16.59%
11.93%
37.38%
 
EPS
20.68
16.71
21.30
17.02
22.66
12.78
7.74
4.81
5.76
5.15
3.75

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
3,225.54
2,834.91
2,586.54
2,173.27
1,843.72
1,529.47
1,304.18
903.60
661.60
431.16
Share Capital
24.24
24.20
24.80
24.77
25.42
25.42
25.38
22.87
21.67
20.43
Total Reserves
3,183.00
2,792.68
2,545.01
2,126.23
1,800.02
1,493.09
1,273.38
878.28
611.13
410.74
Non-Current Liabilities
176.04
254.73
282.83
366.30
485.98
552.63
488.19
187.99
246.62
356.52
Secured Loans
68.97
148.64
233.70
333.81
414.83
478.78
433.13
123.90
183.66
302.59
Unsecured Loans
0.00
0.00
0.00
0.00
6.69
0.00
0.00
0.34
0.55
0.62
Long Term Provisions
37.88
29.26
28.31
24.84
21.50
12.58
7.70
7.25
5.58
4.03
Current Liabilities
2,082.29
1,813.50
1,641.60
1,173.10
893.40
896.48
877.91
787.13
654.75
415.03
Trade Payables
749.53
782.13
638.61
541.05
356.88
323.48
274.35
215.98
181.10
187.63
Other Current Liabilities
261.08
193.19
200.85
194.25
153.16
113.60
69.84
93.43
79.21
88.98
Short Term Borrowings
1,054.24
810.88
765.58
409.27
371.69
454.21
525.10
473.83
392.85
124.97
Short Term Provisions
17.45
27.31
36.56
28.53
11.66
5.20
8.62
3.90
1.58
13.45
Total Liabilities
5,483.87
4,903.14
4,511.53
3,712.67
3,223.10
2,978.58
2,670.28
1,878.72
1,562.97
1,202.71
Net Block
2,095.62
1,910.92
1,541.17
1,332.00
1,203.97
944.25
776.73
644.34
559.94
616.55
Gross Block
3,351.81
2,981.22
2,461.77
2,145.15
1,875.23
1,472.94
1,199.63
983.66
822.98
843.76
Accumulated Depreciation
1,256.19
1,070.30
920.59
813.15
671.26
528.69
422.90
339.32
263.05
227.21
Non Current Assets
2,578.83
2,328.99
2,006.54
1,715.68
1,594.41
1,696.34
1,483.71
1,050.55
744.97
699.69
Capital Work in Progress
271.70
239.39
356.23
239.08
294.20
495.95
514.52
267.43
76.56
62.03
Non Current Investment
21.52
21.21
19.67
18.99
19.34
210.42
156.56
108.23
70.11
0.19
Long Term Loans & Adv.
190.00
157.47
89.47
125.61
76.89
45.72
35.91
30.56
38.37
20.76
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.15
Current Assets
2,905.05
2,574.15
2,504.99
1,997.00
1,628.70
1,282.24
1,186.57
828.16
818.00
500.36
Current Investments
0.00
0.00
0.00
0.00
109.85
0.00
0.00
0.00
0.00
0.00
Inventories
1,300.55
1,149.41
978.55
782.18
438.43
384.21
279.95
269.18
253.72
224.52
Sundry Debtors
985.83
948.54
924.95
765.42
662.04
673.54
628.25
417.70
375.35
136.91
Cash & Bank
386.38
312.79
409.46
271.04
283.94
89.04
115.64
49.80
130.29
65.31
Other Current Assets
232.28
49.22
61.67
50.74
134.43
135.45
162.73
91.49
58.65
73.63
Short Term Loans & Adv.
186.00
114.19
130.35
127.61
91.83
98.46
114.09
51.66
48.68
2.05
Net Current Assets
822.75
760.65
863.38
823.90
735.30
385.76
308.65
41.03
163.25
85.33
Total Assets
5,483.88
4,903.14
4,511.53
3,712.68
3,223.11
2,978.58
2,670.28
1,878.71
1,562.97
1,202.72

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
439.41
738.75
332.06
432.48
476.19
262.24
-0.65
188.24
151.43
150.28
PBT
547.23
687.17
558.00
704.36
425.64
276.78
180.00
204.99
186.03
127.96
Adjustment
328.80
237.69
176.29
194.43
156.88
149.85
107.45
95.14
92.63
85.37
Changes in Working Capital
-246.32
-10.31
-257.19
-274.95
12.75
-75.94
-230.03
-52.37
-79.70
-31.34
Cash after chg. in Working capital
629.71
914.55
477.11
623.84
595.27
350.69
57.42
247.77
198.97
182.00
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-190.30
-175.80
-145.05
-191.37
-119.08
-88.45
-58.07
-59.53
-47.54
-31.72
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-360.16
-191.36
-380.12
-277.13
-160.63
-269.82
-462.31
-326.09
-161.65
-145.55
Net Fixed Assets
-101.04
-104.53
-302.61
-204.42
-124.57
-176.36
-282.01
-249.86
-75.62
-231.53
Net Investments
-264.87
-80.00
-5.00
-36.29
-48.78
-431.34
-0.01
13.84
-16.48
72.98
Others
5.75
-6.83
-72.51
-36.42
12.72
337.88
-180.29
-90.07
-69.55
13.00
Cash from Financing Activity
7.66
-440.29
190.00
-299.31
-212.85
-17.43
528.62
55.87
85.67
18.83
Net Cash Inflow / Outflow
86.92
107.10
141.94
-143.97
102.70
-25.01
65.66
-81.98
75.44
23.56
Opening Cash & Equivalents
291.56
184.71
41.84
185.93
83.02
108.03
42.37
124.35
54.85
41.75
Closing Cash & Equivalent
381.10
291.56
184.71
41.84
185.93
83.02
108.03
42.37
130.29
65.31

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
132.33
116.38
103.62
86.85
71.80
59.73
51.17
39.40
29.20
20.98
ROA
7.80%
10.97%
10.04%
15.84%
9.99%
6.64%
5.13%
8.12%
9.03%
8.31%
ROE
13.46%
19.18%
17.49%
27.64%
18.54%
13.32%
10.60%
18.23%
23.53%
23.29%
ROCE
15.66%
19.63%
17.37%
25.42%
17.22%
12.71%
11.09%
16.57%
20.16%
18.75%
Fixed Asset Turnover
1.42
1.66
1.63
1.97
1.75
1.78
1.55
1.59
1.66
1.77
Receivable days
78.34
75.78
81.94
65.94
83.34
100.03
112.83
100.84
67.60
33.47
Inventory Days
99.22
86.07
85.35
56.39
51.34
51.03
59.23
66.49
63.11
54.79
Payable days
138.29
112.38
114.29
117.79
58.20
54.96
62.37
64.87
59.99
53.57
Cash Conversion Cycle
39.26
49.48
52.99
4.54
76.48
96.10
109.70
102.46
70.72
34.69
Total Debt/Equity
0.38
0.38
0.43
0.39
0.49
0.65
0.75
0.73
1.01
1.14
Interest Cover
6.17
13.29
25.04
27.80
16.75
10.72
6.44
7.36
6.02
4.96

News Update:


  • USFDA concludes inspection at Granules India’s API facility in Hyderabad
    21st Jun 2025, 10:58 AM

    The inspection was conducted from June 16, 2025 to June 20, 2025 and conluded with one 483 observation

    Read More
  • Granules India acquires Senn Chemicals AG
    11th Apr 2025, 12:12 PM

    The company has forayed into the CDMO space with the acquisition of Senn Chemicals AG

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.